Skip to main content

Sofinnova Investments, Inc.

Position in COGT — Cogent Biosciences, Inc.

CIK 1631134 Menlo Park, CA

Position in COGT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$40,060,227
-$41,290,350 QoQ
Shares Held
1,035,148
-51.0% QoQ
Ownership
0.597%
of shares outstanding
% of Portfolio
2.14%
of 13F equity value
Holder Rank
#39
of 323 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in COGT Over Time

Shares Held

Position Value (USD)

Derivatives in COGT

reported options exposure · as of Jun 30, 2025
CallValue
$4,738,800
CallShares
660,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Sofinnova Investments, Inc. holds $1,182,454,857 across 43 Biotechnology names. COGT ranks #9 (3.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in COGT

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $40,060,227 1,035,148
2026-03-31 $81,350,577 2,113,551
2025-12-31 $70,103,160 1,973,625
2025-09-30 $30,557,232 2,127,941
2025-06-30 $16,912,525 2,355,505
2025-06-30 $4,738,800 660,000
2025-03-31 $13,070,904 2,182,121
2024-12-31 $6,420,648 823,160
2024-09-30 $24,464,484 2,265,230
2024-06-30 $23,378,800 2,773,286
2024-03-31 $16,133,181 2,400,771